Anonymous
Guest
Anonymous
Guest
Bye bye Shire. FDA fine and takeover are imminent....
Cafepharma: reliable and accurate information you can count on!
http://www.pharmatimes.com/Article/...s_for_US_Clinical_Researcher_of_the_Year.aspx
New quality standards unveiled as entry opens for US Clinical Researcher of the Year
Clinical News | March 29, 2012
Staff Reporter
Senior clinical executives from top pharmaceutical companies, including AstraZeneca, Sanofi, Shire and GSK, met earlier this month at the US offices of Shire Pharmaceuticals to agree the quality standards and define the competencies for a global competition to recognise and encourage talented researchers in North and South America.
The US Clinical Researcher of the Year competition (www.usclinicalresearcher.com) is an important initiative because it provides professionals working within the clinical research fraternity with the opportunity for personal development through a series of peer-mediated and competency-based exercises.
Jim Thomasell, executive director of competition partner and sponsor, the Association of Clinical Research Professionals, notes: “ACRP is delighted to support the US Clinical Researcher of the Year competition, because its aims are very much aligned with our mission, namely to provide leadership to promote integrity and excellence for the clinical research profession.”
The case-study nature of the competition means participants and the organisations supporting them have no concerns over sharing sensitive information regarding their day-to-day work. And, importantly, competitors can test their skills and knowledge to challenge themselves within the protected environment of an industry competition....